Mike Tarlov and Rich 250x250Join us for an enlightening episode of BioTalk with Rich Bendis, featuring Michael J. Tarlov, Chief of the Biomolecular Measurement Division at the Material Measurement Laboratory, NIST. With a distinguished career in analytical chemistry and extensive experience in biochemical sensing and bioprocess measurements, Michael leads critical initiatives to advance biotechnology and healthcare.

In this episode, we delve into the pivotal role of NIST as a non-regulatory agency within the Department of Commerce, highlighting its profound impact on measurement science, gene therapy, gene editing, synthetic biology, and regenerative medicine. Michael shares insights into NIST's collaborations, including local companies like MedImmune/AstraZeneca and Novavax, and the importance of partnerships with academic institutions like the University of Maryland in driving local biotech advancements.

Listen now via:

We also explore specific technologies and standards such as gene delivery systems, the NIST Monoclonal Antibody Reference Material (NISTmAb), and the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). Michael discusses the goals for future research and collaborations and reveals the next big developments we should anticipate in the biotech field.

Don't miss this engaging conversation as we uncover the innovations and initiatives at NIST that are shaping the future of biotechnology and healthcare.

Michael Tarlov is chief of the Biomolecular Measurement Division, which develops the measurement science, standards, technology, and data required to support the nation's needs for determining the composition, structure, quantity, and function of biomolecules. This work will help to advance biotechnology, DNA forensics, biomedical and bioscience research, and health care. Mike Tarlov received a Ph.D. in analytical chemistry from the University of Minnesota. During his career at NIST he has authored or co-authored more than 80 publications in the areas of self-assembled monolayers, biochemical sensing, and bioprocess measurements.  Mike was formerly chief of the Process Measurements Division, and was acting chief of the Biochemical Science Division.  Mike is also responsible for leading the cross-division NIST Biomanufacturing Program, which develops measurement science, standards, and reference data to support the development, manufacturing, and regulatory approval of protein drugs.